Johnson & Johnson (JNJ) vs Platinum Futures (PLATINUM)
See how Johnson & Johnson and Platinum Futures differ across market data and performance, so you can decide which asset best fits your strategy.
$253.04
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
Platinum Futures represent standardized exchange-traded contracts linked to the future price of platinum. They are used by producers, consumers, traders, and investors to hedge exposure, express views on supply and demand, or gain commodity-market exposure. Their price is influenced by auto-catalyst demand, jewelry demand, industrial use, mine supply, investor flows, and the U.S. dollar.